MassBio Responds to New FDA Leadership Concerns
May 09, 2026
May 09, 2026
CAMBRIDGE, Massachusetts, May 9 -- The Massachusetts Biotechnology Council posted the following statement on May 8, 2026:
* * *
MassBio responds to new FDA leadership concerns
MassBio CEO & President Kendalle Burlin O'Connell posted the following statement in response to original reporting from The Wall Street Journal regarding plans by the White House to remove FDA Commissioner Marty Makary from his position:
FDA leadership instabilit . . .
* * *
MassBio responds to new FDA leadership concerns
MassBio CEO & President Kendalle Burlin O'Connell posted the following statement in response to original reporting from The Wall Street Journal regarding plans by the White House to remove FDA Commissioner Marty Makary from his position:
FDA leadership instabilit . . .
